OncoScape

Exploring the cancer aberration landscape by genomic data fusion

Journal Article (2016)
Authors

A Schlicker (Nederlands Kanker Instituut - Antoni van Leeuwenhoek ziekenhuis)

Magali Michaut (Nederlands Kanker Instituut - Antoni van Leeuwenhoek ziekenhuis)

Rubayte Rahman (Nederlands Kanker Instituut - Antoni van Leeuwenhoek ziekenhuis)

L.F.A. Wessels (Nederlands Kanker Instituut - Antoni van Leeuwenhoek ziekenhuis, TU Delft - Pattern Recognition and Bioinformatics)

Research Group
Pattern Recognition and Bioinformatics
Copyright
© 2016 A Schlicker, Magali Michaut, Rubayte Rahman, L.F.A. Wessels
To reference this document use:
https://doi.org/10.1038/srep28103
More Info
expand_more
Publication Year
2016
Language
English
Copyright
© 2016 A Schlicker, Magali Michaut, Rubayte Rahman, L.F.A. Wessels
Research Group
Pattern Recognition and Bioinformatics
Pages (from-to)
1-11
DOI:
https://doi.org/10.1038/srep28103
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

Although large-scale efforts for molecular profiling of cancer samples provide multiple data types for many samples, most approaches for finding candidate cancer genes rely on somatic mutations and DNA copy number only. We present a new method, OncoScape, which exploits five complementary data types across 11 cancer types to identify new candidate cancer genes. We find many rarely mutated genes that are strongly affected by other aberrations. We retrieve the majority of known cancer genes but also new candidates such as STK31 and MSRA with very high confidence. Several genes show a dual oncogene- and tumor suppressor-like behavior depending on the tumor type. Most notably, the
well-known tumor suppressor RB1 shows strong oncogene-like signal in colon cancer. We applied OncoScape to cell lines representing ten cancer types, providing the most comprehensive comparison of aberrations in cell lines and tumor samples to date. This revealed that glioblastoma, breast and colon cancer show strong similarity between cell lines and tumors, while head and neck squamous cell carcinoma and bladder cancer, exhibit very little similarity between cell lines and tumors. To facilitate exploration of the cancer aberration landscape, we created a web portal enabling interactive analysis of OncoScape results (http://ccb.nki.nl/software/oncoscape).